450 likes | 711 Views
Radiologic Evaluation of Intracranial Tumors. Todd Gourdin M-IV Radiology Final Presentation August 2, 2007. Available Modalities. 1)X-ray 2)CT 3)MRI 4)Nuclear Medicine. X-ray. Primarily of historical interest since the onset of CT in 1974.
E N D
Radiologic Evaluation of Intracranial Tumors Todd Gourdin M-IV Radiology Final Presentation August 2, 2007
Available Modalities 1)X-ray 2)CT 3)MRI 4)Nuclear Medicine
X-ray Primarily of historical interest since the onset of CT in 1974. Was useful for detecting increased intracranial pressure and intracranial calcifications.
CT Most intracranial neoplasms are visible on CT Tumors may be hypodense, isodense, or hyperdense on a noncontrast CT depending on tumor histology and location
Small tumors or isodense tumors may be missed on noncontrast CT but highlight after contrast administration - Meningiomas and Neuromas enhance strongly with contrast while low-grade gliomas and epidermoid tumors do not enhance.
Why not MRI them all??? MRI is generally preferable to CT for evaluating intracranial neoplasms CT is preferred for visualizing tumor calcification or intratumor hemorrhage.
Commonly Calcified and Hemorrhagic Lesions Calcified Hemorrhagic Oligodendroglioma Glioblastoma multiforme Choroid Plexus tumor Oligodendroglioma Ependymoma Metastatic: Central neurocytoma Melanoma Craniopharyngioma Breast Teratoma Lung Chordoma
MRI Usually the preferred method of imaging intracranial tumors due to better soft-tissue contrast MRI exploits increased water content of many neoplasms. This water content shows up as increased signal on T2 weighted images and decreased signal on T1 Images.
Contrast(often IV Gadolinium) helps visualize small tumors that don’t cause much edema.
Advanced MRI Techniques “This stuff is complicated!!!!”
Proton Magnetic Resonance Spectroscopy Analyzes the biochemical makeup of a tumor to create a characteristic spectroscopic pattern. - Computer analysis of the pattern allows histologic type to be determined non-invasively.
Figure 98-3Proton magnetic resonance spectroscopy; the choline peak (3.22 p.p.m.) is elevated, the creatine peak (3.03 p.p.m.) is low and the N-acetyl aspartate peak (2.01 p.p.m.) is nearly undetectable; characteristic spectroscopic appearance of gliomas (choline—CHO; creatine—PCr/Cr; N-acetyl aspartate—NAA). “Grainger and Allison’s Diagnostic Radiology, 2001”
Perfusion weighted MRI Technique used to determine the relative cerebral blood volume (rCBV) of intracranial structures. - Many tumors are highly vascularized allowing them to be distinguished from the background on a perfusion weighted MRI.
Meningioma T2 Contrasted T1 Perfusion-Weighted
MRI-guided Surgery A variety of techniques have been developed to incorporate MRI into the surgical process for intracranial tumor resection: MRI guided stereotactic biopsy Brain surface imaging Interventional MRI
Nuclear Medicine SPECT(Single Photon Emission Computed Tomography) Gamma rays emitted during radionuclide decay are detected by a gamma camera that rotates about the patient’s head - The radionuclides must cross the blood-brain barrier
Radionuclides preferentially taken up by intracranial neoplasms include: 201 TI Chloride 99m Tc MIBI 123 I a-methyl tyrosine 111 In octreotide - Can be used for example in distinguishing between benign lesions, low-grade gliomas, and high-grade gliomas
SPECT of Normal Brain Radionuclide = 99m TC
201 T1 SPECT Diagnosed by SPECT as a high-grade glioma and confirmed post-resection
PET(Positron Emission Tomography) Similar to SPECT but the radioisotopes used decay to produce positrons These positrons quickly combine with an adjacent electron to produce two gamma rays that travel in opposite directions. Detection of these gamma rays allows calculation of their exact point of origin. Can evaluate different brain processes depending on the radioisotope selected
Radionuclides useful for PET analysis of intracranial tumors include: Fluorodeoxyglucose C methionine F a-methyl tyrosine
Advantages of PET over SPECT: - Can be used to quantify emission Better resolution Disadvantages of PET: Cost Limited availability Need for a cyclotron(particle accelerator)
PET scan of Language Center Figure 98-4H215O PET activation study during a language task in a young man with a right frontal glioma, before neurosurgical resection. Language activation is seen bilaterally and is distant from the tumour. “Grainger and Allison’s Diagnostic Radiology, 2001”
Classification of Intracranial Neoplasms 1)Neuroepithelial Origin – astrocytoma, oligodendroglioma, ependymoma, mixed glioma, choroid plexus tumor, neuronal tumor, pineal tumor. -Gliomas(astrocytomas, oligodendroglioma, ependymoma) = approximately 50% of primary brain tumors -Graded from 1 -4 based on severity -Grade 4 = Glioblastoma Multiforme – most common primary intracranial neoplasm
GBM • Hallmark finding is tumor necrosis • Often cross the midline • Extremely poor prognosis
2)Tumors of Nerve Sheath – Schwannoma, Neurofibroma - These are cranial nerve sheath tumors that show marked enhancement with IV contrast
3)Meningeal tumors – meningioma Originate from “arachnoid cell rests” in the dura matter Commonly arise from parasagittal region, cerebral convexities, sphenoid ridge, and olfactory groove Often contain calcifications and enhance well with IV contrast Represents approximately 15% of primary intracranial tumors
4)Lymphoma 2-3% of intracranial neoplasms Well defined, rounded lesions that appear hyperdense on noncontrast CT and enhace well with contrast Lymphomas may appear “atypical” in the immunocompromised
5)Metastasis Usually multiple lesions which help distinguish them from supratentorial gliomas Often found at grey/white matter junction
6)Additional classes include: germ cell tumors, dermoid/epidermoid cysts, sellar/pituitary tumors,
References Harvard University Dept. of Radiology www.brighamrad.harvard.edu LSU Dept. of Radiology www.medschool.lsuhsc.edu University of South Carolina Dept. of Radiology www.radiology.med.sc.edu Grainger and Allison’s Diagnostic Radiology: A Textbook of Medical Imaging, 4th ed. 2001 Churchill Livinstone Inc., 2001.